chr1-207468705-C-G
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001006658.3(CR2):āc.624C>Gā(p.Pro208Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0111 in 1,613,976 control chromosomes in the GnomAD database, including 140 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ). Synonymous variant affecting the same amino acid position (i.e. P208P) has been classified as Likely benign.
Frequency
Consequence
NM_001006658.3 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -21 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CR2 | NM_001006658.3 | c.624C>G | p.Pro208Pro | synonymous_variant | 3/20 | ENST00000367057.8 | NP_001006659.1 | |
CR2 | NM_001877.5 | c.624C>G | p.Pro208Pro | synonymous_variant | 3/19 | NP_001868.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CR2 | ENST00000367057.8 | c.624C>G | p.Pro208Pro | synonymous_variant | 3/20 | 1 | NM_001006658.3 | ENSP00000356024.3 |
Frequencies
GnomAD3 genomes AF: 0.00912 AC: 1387AN: 152136Hom.: 9 Cov.: 32
GnomAD3 exomes AF: 0.00901 AC: 2264AN: 251408Hom.: 22 AF XY: 0.00904 AC XY: 1228AN XY: 135878
GnomAD4 exome AF: 0.0114 AC: 16603AN: 1461722Hom.: 131 Cov.: 33 AF XY: 0.0111 AC XY: 8097AN XY: 727162
GnomAD4 genome AF: 0.00911 AC: 1387AN: 152254Hom.: 9 Cov.: 32 AF XY: 0.00998 AC XY: 743AN XY: 74454
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Oct 19, 2023 | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2024 | CR2: BP4, BP7, BS1, BS2 - |
Immunodeficiency, common variable, 7 Benign:2
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Apr 11, 2023 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
CR2-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 04, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Systemic lupus erythematosus, susceptibility to, 9;C3150354:Immunodeficiency, common variable, 2;C3542922:Immunodeficiency, common variable, 7 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Apr 04, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at